跳转至内容
Merck
  • Adenosine modulates light responses of rat retinal ganglion cell photoreceptors througha cAMP-mediated pathway.

Adenosine modulates light responses of rat retinal ganglion cell photoreceptors througha cAMP-mediated pathway.

The Journal of physiology (2014-07-20)
Puneet Sodhi, Andrew T E Hartwick
摘要

Adenosine is an established neuromodulator in the mammalian retina, with A1 adenosine receptors being especially prevalent in the innermost ganglion cell layer. Activation of A1 receptors causes inhibition of adenylate cyclase, decreases in intracellular cyclic AMP (cAMP) levels and inhibition of protein kinase A (PKA). In this work, our aim was to characterize the effects of adenosine on the light responses of intrinsically photosensitive retinal ganglion cells (ipRGCs) and to determine whether these photoreceptors are subject to neuromodulation through intracellular cAMP-related signalling pathways. Using multielectrode array recordings from postnatal and adult rat retinas, we demonstrated that adenosine significantly shortened the duration of ipRGC photoresponses and reduced the number of light-evoked spikes fired by these neurons. The effects were A1 adenosine receptor-mediated, and the expression of this receptor on melanopsin-containing ipRGCs was confirmed by calcium imaging experiments on isolated cells in purified cultures. While inhibition of the cAMP/PKA pathway by adenosine shortened ipRGC light responses, stimulation of this pathway with compounds such as forskolin had the opposite effect and lengthened the duration of ipRGC spiking. Our findings reveal that the modification of ipRGC photoresponses through a cAMP/PKA pathway is a general feature of rat ganglion cell photoreceptors, and this pathway can be inhibited through activation of A1 receptors by adenosine. As adenosine levels in the retina rise at night, adenosinergic modulation of ipRGCs may serve as an internal regulatory mechanism to limit transmission of nocturnal photic signals by ipRGCs to the brain. Targeting retinal A1 adenosine receptors for ipRGC inhibition represents a potential therapeutic target for sleep disorders and migraine-associated photophobia.

材料
货号
品牌
产品描述

Sigma-Aldrich
毛喉素, from Coleus forskohlii, ≥98% (HPLC), powder
Sigma-Aldrich
次磷酸 溶液, 50 wt. % in H2O
Sigma-Aldrich
磷酸钠, 96%
Sigma-Aldrich
毛喉素, For use in molecular biology applications
Sigma-Aldrich
腺苷, ≥99%
Sigma-Aldrich
8-溴腺苷-3',5'-环单磷酸 钠盐, ≥97% (HPLC), powder
Sigma-Aldrich
腺苷-3′,5′-环单磷酸, ≥98.5% (HPLC), powder
Sigma-Aldrich
腺苷, suitable for cell culture, BioReagent
Sigma-Aldrich
氨甲基膦酸, 99%
Sigma-Aldrich
番木鳖碱
Sigma-Aldrich
8-环戊基-1,3-二丙基黄嘌呤, solid
Sigma-Aldrich
腺苷
Sigma-Aldrich
8-溴鸟嘌呤3',5'-环一磷酸 钠盐, ≥98% (HPLC), powder
Sigma-Aldrich
腺苷-3′,5′-环单磷酸 三羟甲基氨基甲烷盐, ≥97% (HPLC), powder
Sigma-Aldrich
L-(+)-2-氨基-4-膦酰基丁酸, optical purity optical purity: ≥95% (HPLC, Marfey′s reagent)
Sigma-Aldrich
8-(4-氯苯硫基)-鸟苷 3′,5'-环单磷酸 钠盐, ≥95% (HPLC), powder
Sigma-Aldrich
β-D-阿洛糖, rare aldohexose sugar
Supelco
氨甲基膦酸, PESTANAL®, analytical standard
Supelco
毛喉素, analytical standard
阿托品, European Pharmacopoeia (EP) Reference Standard
Supelco
腺苷, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
次磷酸 溶液, SAJ first grade, 30.0-32.0% in H2O
腺苷, European Pharmacopoeia (EP) Reference Standard
峰鉴别用阿托品, European Pharmacopoeia (EP) Reference Standard